Riccardi, Laura
 Distribuzione geografica
Continente #
EU - Europa 2.562
NA - Nord America 2.419
AS - Asia 1.928
SA - Sud America 379
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 7.342
Nazione #
US - Stati Uniti d'America 2.345
DE - Germania 1.066
SG - Singapore 946
CN - Cina 553
SE - Svezia 372
BR - Brasile 311
IT - Italia 310
GB - Regno Unito 136
FR - Francia 129
UA - Ucraina 127
IE - Irlanda 105
FI - Finlandia 86
RU - Federazione Russa 74
VN - Vietnam 68
IN - India 63
ID - Indonesia 60
TR - Turchia 51
CA - Canada 38
PL - Polonia 30
HK - Hong Kong 27
AR - Argentina 25
NL - Olanda 24
JP - Giappone 21
KR - Corea 20
MX - Messico 19
BD - Bangladesh 17
IQ - Iraq 17
BE - Belgio 16
AT - Austria 14
ES - Italia 14
IR - Iran 12
LT - Lituania 12
CI - Costa d'Avorio 11
CZ - Repubblica Ceca 11
EC - Ecuador 11
ZA - Sudafrica 11
TW - Taiwan 10
PE - Perù 9
SA - Arabia Saudita 9
VE - Venezuela 8
EU - Europa 7
IL - Israele 7
CH - Svizzera 6
MA - Marocco 6
PH - Filippine 6
PK - Pakistan 6
RO - Romania 6
AU - Australia 5
CL - Cile 5
KE - Kenya 5
KG - Kirghizistan 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
HN - Honduras 4
PA - Panama 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CO - Colombia 3
JM - Giamaica 3
JO - Giordania 3
NP - Nepal 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
MK - Macedonia 2
NO - Norvegia 2
PY - Paraguay 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
PS - Palestinian Territory 1
SN - Senegal 1
TH - Thailandia 1
Totale 7.342
Città #
Singapore 485
Chandler 355
Dallas 254
Ashburn 213
New York 148
Dublin 103
Beijing 90
Hefei 83
Los Angeles 81
Milan 70
Munich 70
Nürnberg 68
Rome 68
Jacksonville 67
San Mateo 62
Jakarta 58
Ann Arbor 48
Nanjing 44
Boston 42
The Dalles 42
Helsinki 39
Marseille 37
Bremen 36
Zhengzhou 36
Moscow 35
Izmir 31
Wilmington 31
Princeton 29
Frankfurt am Main 28
São Paulo 28
Cattolica 27
Dearborn 27
Kent 27
Hong Kong 26
Buffalo 23
Chicago 23
Warsaw 23
Turku 21
Ho Chi Minh City 20
Seoul 20
Boardman 19
Hanoi 19
Nanchang 19
Toronto 18
Brooklyn 17
London 17
Tokyo 17
Brussels 16
Tianjin 16
Woodbridge 16
Düsseldorf 14
Kunming 14
Nuremberg 14
Redwood City 14
Seattle 14
Hebei 13
Lancaster 12
Phoenix 12
Shenyang 12
Abidjan 11
Leawood 11
Stockholm 11
Denver 10
Pune 10
Atlanta 9
Baghdad 9
Lawrence 9
Montreal 9
Santa Clara 9
Shanghai 9
Fairfield 8
Florence 8
Jinan 8
Mountain View 8
Rio de Janeiro 8
Taipei 8
Augusta 7
Cambridge 7
Chennai 7
Houston 7
Jiaxing 7
Johannesburg 7
Mexico City 7
North Bergen 7
Norwalk 7
Poplar 7
Portsmouth 7
Vienna 7
Amsterdam 6
Andover 6
Ankara 6
Belo Horizonte 6
Bexley 6
Changsha 6
Curitiba 6
Dhaka 6
Orem 6
Paris 6
Bishkek 5
Cimitile 5
Totale 3.620
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 440
A phase II study of sunitinib in advanced hepatocellular carcinoma 242
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 209
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection 195
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 185
Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm 179
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 176
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 173
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 164
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 163
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 155
Liver transplantation in patients with alcoholic liver disease: A retrospective study 154
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 153
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 152
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 152
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 148
Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study 145
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis 143
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 129
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 126
Correlation Between QElaXto Techniques and Supersonic Imagine for Liver Stiffness Quantification in Chronic Liver Disease 125
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes. 122
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 121
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 119
Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease 118
Dynamic Contrast-Enhanced Ultrasound in the Prediction of Advanced Hepatocellular Carcinoma Response to Systemic and Locoregional Therapies 111
Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment 111
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 111
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 110
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 110
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals 109
Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience 103
The role of elastography in non-Alcoholic fatty liver disease 102
Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial 100
Diffuse liver infiltration by lobular breast carcinoma: Shear wave elastography as gold standard imaging study. 98
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 96
Minimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study 96
The Gemelli Ultrasound Chronic Pancreatitis Score: A Non-invasive Tool for the Diagnosis of Chronic Pancreatitis 92
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 92
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 90
Elastography assessment in patients with chronic HCV infection 89
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy 89
Clinical impact of comorbidities in an Italian NAFLD cohort 88
ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study 87
Assessing Baveno VI criteria with liver stiffness measured using a new point-shear wave elastography technique (BAVElastPQ study) 80
Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives 78
Hepatocellular carcinomas <2 cm in diameter complicating cirrhosis: ultrasound and clinical features in 153 consecutive patients 78
A new ultrasound score for the assessment and follow-up of chronic pancreatitis: The ‘Gemelli USCP score’ 77
COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT 76
Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate 76
Correlation between a New Point-Shear Wave Elastography Device (X+pSWE) with Liver Histology and 2D-SWE (SSI) for Liver Stiffness Quantification in Chronic Liver Disease 75
Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular Carcinoma 75
Effectiveness of Radiofrequency Ablation of Hepatocellular Carcinoma 74
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 72
New Therapeutic Perspectives for Management of Advanced Hepatocellular Carcinoma With Hepatic Arteriovenous Fistula: Balloon-Occluded Percutaneous Radio-Frequency Thermal Ablation (RFA) Plus Transcatheter Arterial Chemoembolization (TACE) 68
Prognostic value of liver stiffness in patients hospitalized for acute decompensated heart failure: a meta-analysis 66
The Role of Transabdominal Ultrasound Elastography in Gastrointestinal Non-Liver Diseases: Current Application and Future Prospectives 65
Single-Step Balloon-Occluded Percutaneous Radio-Frequency Thermal Ablation (RFA) Plus Transcatheter Arterial Chemoembolization (TACE) for Treatment of "Complex" Unresectable Hepatocellular Carcinoma 61
Treatment of Portal Vein Tumor Thrombosis (PVTT) Can Impact Survival of Patients With Advanced HCC? 60
Shear Wave Dispersion in Chronic Liver Disease: From Physical Principles to Clinical Usefulness 58
Dynamic contrast enhanced ultrasound in gastrointestinal diseases: A current trend or an indispensable tool? 55
Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn’s disease treated with ustekinumab 52
Performance of Noninvasive Tests for Metabolic Dysfunction-Associated Steatohepatitis and Liver Fibrosis Resolution after Bariatric Surgery 33
Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial 32
bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial 28
Totale 7.411
Categoria #
all - tutte 29.796
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.796


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021163 0 0 0 0 0 16 21 5 37 24 53 7
2021/2022411 20 27 13 25 31 8 10 69 14 37 64 93
2022/20231.110 140 133 85 184 55 112 71 95 122 28 49 36
2023/2024645 23 141 33 31 30 138 41 24 10 36 57 81
2024/20251.442 36 29 123 70 125 52 52 106 186 130 287 246
2025/20262.038 454 105 418 412 612 37 0 0 0 0 0 0
Totale 7.411